CD8A and breast cancer: demonstrated that PD‐1+ CD8+ T cells, characterized by exhaustion markers, cytotoxic markers, and immune cell homing markers such as CXCL13, underwent clonal expansion following anti‐PD‐1 treatment in breast cancer.[97] In colorectal cancer (CRC), Chen et al.